Evidence map›Paper›PMID 39779890›Full record

ReviewNature metabolism2025

Cellular and organismal function of choline metabolism.

Timothy C Kenny, Samantha Scharenberg, Monther Abu-Remaileh, Kıvanç Birsoy

Abstract readReview
In one paragraph

Review in Nature metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Freeze-DriedBiomolecules · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Biomimetic Construction of Abiotic Membranes Through Acylation of Cationic Diamino Acids.Chembiochem : a European journal of chemical biology · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Timothy C Kenny *Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA.
Samantha Scharenberg *Department of Chemical Engineering, Stanford University, Stanford, CA, USA.
Monther Abu-RemailehDepartment of Chemical Engineering, Stanford University, Stanford, CA, USA. monther@stanford.edu.ORCID http://orcid.org/0000-0003-3772-0477
Kıvanç BirsoyLaboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA. kbirsoy@rockefeller.edu.ORCID http://orcid.org/0000-0002-7579-9895

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007365 · NIGMS · STANFORD UNIVERSITY · PI CHUA, KATRIN F · 1985 to 2021
$33.8M
Identification of metabolic regulators of glycerolipid synthesis and storageR01DK123323 · NIDDK · ROCKEFELLER UNIVERSITY · PI BIRSOY, KIVANC · 2019 to 2023
$2.5M
Stanford ChEM-H Chemistry/Biology Interface Predoctoral Training ProgramT32GM139791 · NIGMS · STANFORD UNIVERSITY · PI Carolyn Bertozzi, Christine Jacobs-Wagner · 2021 to 2026
$2.4M
Innovations and mechanisms in tumor subcellular metabolismDP2CA271386 · NCI · STANFORD UNIVERSITY · PI ABU-REMAILEH, MONTHER · 2021 to 2024
$2.4M
The physiological and molecular function of choline transport in health and metabolic diseaseR01DK140337 · NIDDK · ROCKEFELLER UNIVERSITY · PI Kivanc Birsoy · 2024 to 2026
$2.2M
Understanding the regulation of ER GPATs to control glycerolipid synthesis in diseaseF32DK127836 · NIDDK · ROCKEFELLER UNIVERSITY · PI KENNY, TIMOTHY COLE · 2021 to 2023
$202k
Deciphering the role of phospholipid homeostasis in physiology and diseaseK99DK140517 · NIDDK · ROCKEFELLER UNIVERSITY · PI KENNY, TIMOTHY COLE · 2024 to 2025
$182k
Michael J. Fox Foundation for Parkinson's Research (Michael J. Fox Foundation) ASAP-000463NCI NIH HHS DP2 CA271386NIDDK NIH HHS F32 DK127836NIDDK NIH HHS K99 DK140517NIDDK NIH HHS R01 DK123323NIDDK NIH HHS R01 DK140337NIGMS NIH HHS T32 GM007365NIGMS NIH HHS T32 GM139791U.S. Department of Health & Human Services | National Institutes of Health (NIH) 5T32GM139791-03U.S. Department of Health & Human Services | National Institutes of Health (NIH) DP-CA271386U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01 DK123323-01
6 · The paper itself

Abstract

Choline is an essential micronutrient critical for cellular and organismal homeostasis. As a core component of phospholipids and sphingolipids, it is indispensable for membrane architecture and function. Additionally, choline is a precursor for acetylcholine, a key neurotransmitter, and betaine, a methyl donor important for epigenetic regulation. Consistent with its pleiotropic role in cellular physiology, choline metabolism contributes to numerous developmental and physiological processes in the brain, liver, kidney, lung and immune system, and both choline deficiency and excess are implicated in human disease. Mutations in the genes encoding choline metabolism proteins lead to inborn errors of metabolism, which manifest in diverse clinical pathologies. While the identities of many enzymes involved in choline metabolism were identified decades ago, only recently has the field begun to understand the diverse mechanisms by which choline availability is regulated and fuelled via metabolite transport/recycling and nutrient acquisition. This review provides a comprehensive overview of choline metabolism, emphasizing emerging concepts and their implications for human health and disease.

Indexed as

CholineAnimalsHumansCholine

Identifiers

PMID39779890
PMCPMC11990872

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.